183
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Simultaneous determination of aditoprim and its three major metabolites in pigs, broilers and carp tissues, and its application in tissue distribution and depletion studies

, , , , &
Pages 1299-1311 | Received 23 Mar 2016, Accepted 19 May 2016, Published online: 27 Jul 2016

References

  • Alvinerie M, Sutra JF, Eeckhoutte C, Galtier P, van ‘t Klooster GA, van Miert AS. 1993. Determination of aditoprim and its oxidative metabolites in plasma and microsomal incubation mixtures by high-performance liquid chromatography. J Chromatogr. 612:115–121.
  • Ascalone V, Jordan JC, Ludwig BM. 1986. Determination of aditoprim, a new dihydrofolate reductase inhibitor, in the plasma of cows and pigs. J Chromatogr. 383:111–118.
  • Bellmann R. 2014. Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment. Med Klin Intensivmed Notfmed. 109:162–166.
  • [CVMP] Committee for Veterinary Medicinal Products. 2013. Revised reflection paper on injection site residues: considerations for risk assessment and residue surveillance; [cited 2015.Dec 3]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/10/WC500152656.pdf.
  • Damte D, Jeong HJ, Lee SJ, Cho BH, Kim JC, Park SC. 2012. Evaluation of linear regression statistical approaches for withdrawal time estimation of veterinary drugs. Food Chem Toxicol. 50:773–778.
  • Economou A, Petraki O, Tsipi D, Botitsi E. 2012. Development of a liquid chromatography–tandem mass spectrometry method for the determination of sulfonamides, trimethoprim and dapsone in honey and validation according to Commission Decision2002/657/EC for banned compounds. Talanta. 15:32–41.
  • EMEA. 1997a. Trimethoprim. Summary Report (2) (EMEA/MRL/255/97-FINAL); [cited 2015 Dec 3]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015681.pdf.
  • EMEA. 1997b. Baquiloprim. Summary Report (2) (EMEA/MRL/199/97-FINAL); [cited 2015 Dec 3]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500010884.pdf.
  • Engeli J, Riond JL, Wanner M. 1993. Research note: pharmacokinetics of aditoprim in turkeys after intravenous and oral administration. Poult Sci. 72:979–983.
  • FAO/WHO. 2010. Request for data on dietary intake (consumption) of standard and non-standard animal tissues and food of animal origin; [cited 2015 Dec 3]. Available from: http://www.who.int/foodsafety/chem/JECFA75.pdf.
  • Felton T, Troke PF, Hope WW. 2014. Tissue penetration of antifungal agents. Clin Microbiol Rev. 27:68–88.
  • Garwacki S, Lewicki J, Wiechetek M, Grys S, Rutkowski J, Zaremba M. 1996. A study of the pharmacokinetics and tissue residues of an oral trimethoprim/sulphadiazineformulation in healthy pigs. J Vet Pharmacol Ther. 19:423–430.
  • Gehring R, Baynes RE, Wang J, Craigmill AL, Rivierea JE. 2004. A web-based decision support system to estimate extended withdrawal intervals. Comput Electron Agric. 44:145–151.
  • Gros M, Petrović M, Barceló D. 2006. Multi-residue analytical methods using LC-tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review. Anal Bioanal Chem. 386:941–952.
  • Haenni K, Jordan J-C, Ludwig B, Rehm WF. 1987. Pharmacokinetics of aditoprim, a dihydrofolate reductase inhibitor, in sheep. J Vet Pharmacol Ther. 10:169–171.
  • Hawser S, Lociuro S, Islam K. 2006. Dihydrofolate reductase inhibitors as antibacterialagents. Biochem Pharmacol. 71:941–948.
  • Huovinen P. 2001. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis. 32:1608–1614.
  • Iqbal MP, Ashfaq MK, Niazi SK, Mahboobali M, Khawaja KN. 1994. Pharmacokinetics of aditoprim and trimethoprim in buffalo calves. Biopharm Drug Dispos. 15:173–177.
  • Iqbal MP, Niazi SK, Mehboobali N, Zaidi AA. 1995. Disposition kinetics of aditoprim in two monkeys in comparison to other mammalian species. Biopharm Drug Dispos. 16:713–718.
  • JECFA. 2003. 62nd meeting of FAO/WHO joint expert committee on food additives; [cited 2015 Dec 3]. Available from: http://www.fao.org/fileadmin/user_upload/agns/zip/tool_1.1551.zip.
  • Jordan JC, Klatt P, Ludwig B. 1987. Pharmacokinetics of aditoprim, a new long-acting dihydrofolate reductase inhibitor, in heifers. Zentralbl Veterinarmed A. 34:33–41.
  • Knoppert NW, Nijmeijer SM, van Duin CT, Korstanje C, van Gogh H, van Miert AS. 1988. Some pharmacokinetic data of aditoprim and trimethoprim in healthy and tick-borne fever infected dwarf goats. J Vet Pharmacol Ther. 11:135–144.
  • Lohuis JA, Sutter HM, Graser T, Ludwig B, van Miert AS, Rehm WF, Schneider B, Wanner M, van Werven T. 1992. Effects of endotoxin-induced mastitis on the pharmacokinetic properties of aditoprim in dairy cows. Am J Vet Res. 53:2311–2314.
  • Ludwig B. 1989. Use of pharmacokinetics when dealing with the drug residue problem in food-producing animals. Dtsch Tierarztl Wochenschr. 96:243–248.
  • Luo H, Zhang L, Xue F, Li Y, Wang X, Fei C, Zhang C. 2014. Simultaneous determination of trimethoprim and diaveridine in tissues of chicken, porcine, and fish by hydrophilic interaction liquid chromatography-tandem mass spectrometry. Food Anal Method. 7:308–317.
  • Mengelers MJ, Kleter GA, Hoogenboom LA, Kuiper HA, Van Miert AS. 1997. The biotransformation of sulfadimethoxine, sulfadimidine, sulfamethoxazole, trimethoprim and aditoprim by primary cultures of pig hepatocytes. J Vet Pharmacol Therap. 20:24–32.
  • Mengelers MJ, van Klingeren B, van Miert AS. 1990. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents. Am J Vet Res. 51:1860–1864.
  • Riond JL, Muller P, Wanner M. 1992. The influence of age on the pharmacokinetics of aditoprim in pigs after intravenous and oral administration. Vet Res Commun. 16:355–364.
  • Riond JL, Riviere JE. 1990. Allometric analysis of doxycycline pharmacokinetic parameters. J Vet Pharmacol Ther. 13:404–407.
  • Roberts MC. 2002. Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim, and sulfonamide drug classes. Mol Biotechnol. 20:261–283.
  • Sköld O. 2001. Resistance to trimethoprim and sulfonamides. Vet Res. 32:261–273.
  • Stephan-Güldner M. 1993. Preclinical toxicology and safety pharmacology of brodimoprim in comparison to trimethoprim and analogs. J Chemother. 5:400–410.
  • Sutter H-M, Ludwig B, Bremer KD, Jordan J-C, Rehm WF, Wanner M. 1991. Pharmacokinetics of aditoprim in dogs after intravenous and oral administration: a preliminary study. J Small Anim Pract. 32:517–520.
  • Sutter HM, Riond JL, Wanner M. 1993. Comparative pharmacokinetics of aditoprim in milk-fed and conventionally fed calves of different ages. Res Vet Sci. 54:86–93.
  • Then RL, Keller M. 1988. Properties of aditoprim, a new antibacterial dihydrofolate reductase inhibitor. Zentralbl Veterinarmed B. 35:114–120.
  • Toutain PL, Ferran A, Bousquet-Mélou A. 2010. Species differences in pharmacokinetics and pharmacodynamics. Handb Exp Pharmacol. 199:19–48.
  • van Miert AS. 1994. The sulfonamide-diaminopyrimidine story. J Vet Pharmacol Ther. 17:309–316.
  • VICH. 2015a. VICH GL48(R) (MRK): studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: marker residue depletion studies to establish product withdrawal periods; [cited 2015.Dec 3]. Available from: http://www.vichsec.org/guidelines/pharmaceuticals/pharma-safety/metabolism-and-residue-kinetics.html.
  • VICH. 2015b. VICH GL49(R) (MRK): studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: validation of analytical methods used in residue depletion studies; [cited 2015.Dec 3]. Available from: http://www.vichsec.org/guidelines/pharmaceuticals/pharma-safety/metabolism-and-residue-kinetics.html.
  • von Fellenberg RL, Jordan JC, Ludwig B, Rehm WF. 1990. Plasma disposition and tolerance of aditoprim in horses after single intravenous injection. Zentralbl Veterinarmed A. 37:253–258.
  • Wang H, Yuan B, Zeng Z, He L, Ding H, Guo C, Kong X, Wang W, Huang X. 2014. Identification and elucidation of the structure of in vivo metabolites of diaveridine in chicken. J Chromatogr B Analyt Technol Biomed Life Sci. 965:91–99.
  • Wang L, Huang L, Pan Y, Kuča K, Klímová B, Wu Q, Xie S, Ahmad I, Chen D, Tao Y, et al. 2016. Metabolism and disposition of aditoprim in swine, broilers, carp and rats. Sci Rep. doi:10.1038/srep20370
  • Wang X, Tan Z, Cheng G, Awais I, Huang L, Chen D, Pan Y, Liu Z, Yuan Z. 2015. Two-generation reproduction and teratology studies of feeding aditoprim in Wistar rats. J Appl Toxicol. 35:1531–1538.
  • Wang X, Tan Z, Pan Y, Ihsan A, Liu Q, Huang L, Cheng G, Chen D, Tao Y, Liu Z, Yuan Z. 2015. Safety assessment of aditoprim acute, subchronic toxicity and mutagenicity studies. J Appl Toxicol. 35:1415–1426.
  • White G, Daluge SM, Sigel CW, Ferone R, Wilson HR. 1993. Baquiloprim, a new antifolate antibacterial: in vitro activity and pharmacokinetic properties in cattle. Res Vet Sci. 54:372–378.
  • WHO. 2010. Principles and methods for the risk assessment of chemicals in food; [cited 2015.Dec 3]. Available from: http://apps.who.int/iris/bitstream/10665/44065/9/WHO_EHC_240_9_eng_Chapter6.pdf?ua=1.
  • Wolfe GW, Quander R, Kiorpes A, Hall B, Palmer T, Ball D. 1993. Sub-chronic toxicity studies of aditoprim in beagle dogs. Toxicologist. 13:313.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.